-+ 0.00%
-+ 0.00%
-+ 0.00%

This Edwards Lifesciences Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday

Benzinga·04/24/2025 16:17:57
Listen to the news

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • DA Davidson analyst Brian Holland upgraded Utz Brands, Inc. (NYSE:UTZ) from Neutral to Buy and maintained the price target of $16. Utz Brands shares closed at $13.39 on Wednesday. See how other analysts view this stock.
  • JP Morgan analyst Harlan Sur upgraded the rating for Cadence Design Systems, Inc. (NASDAQ:CDNS) from Neutral to Overweight and raised the price target from $300 to $325. Cadence Design Systems shares closed at $265.42 on Wednesday. See how other analysts view this stock.
  • UBS analyst A.J. Rice upgraded Healthcare Services Group, Inc. (NASDAQ:HCSG) from Neutral to Buy and raised the price target from $12 to $15. Healthcare Services shares closed at $12.19 on Wednesday. See how other analysts view this stock.
  • Piper Sandler analyst Adam Maeder upgraded the rating for Edwards Lifesciences Corporation (NYSE:EW) from Neutral to Overweight and raised the price target from $73 to $80. Edwards Lifesciences shares closed at $70.46 on Wednesday. See how other analysts view this stock.
  • Raymond James analyst Michael Rose upgraded Renasant Corporation (NYSE:RNST) from Outperform to Strong Buy and maintained the price target of $40. Renasant shares closed at $31.11 on Wednesday.  See how other analysts view this stock.

Considering buying EW stock? Here’s what analysts think:

Read This Next:

Photo via Shutterstock